Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Operating Margin: 2017-2025

Historic Operating Margin for Assembly Biosciences (ASMB) over the last 6 years, with Sep 2025 value amounting to -100.87%.

  • Assembly Biosciences' Operating Margin rose 5919.00% to -100.87% in Q3 2025 from the same period last year, while for Sep 2025 it was -116.83%, marking a year-over-year increase of 4712.00%. This contributed to the annual value of -159.26% for FY2024, which is 74324.00% up from last year.
  • Assembly Biosciences' Operating Margin amounted to -100.87% in Q3 2025, which was up 12.47% from -115.24% recorded in Q2 2025.
  • In the past 5 years, Assembly Biosciences' Operating Margin ranged from a high of -100.87% in Q3 2025 and a low of -301.81% during Q3 2021.
  • Over the past 3 years, Assembly Biosciences' median Operating Margin value was -149.88% (recorded in 2024), while the average stood at -142.77%.
  • As far as peak fluctuations go, Assembly Biosciences' Operating Margin crashed by 29,019bps in 2021, and later skyrocketed by 7,992bps in 2025.
  • Assembly Biosciences' Operating Margin (Quarterly) stood at -301.81% in 2021, then reached -175.22% in 2023, then spiked by 1,847bps to -156.75% in 2024, then skyrocketed by 5,919bps to -100.87% in 2025.
  • Its Operating Margin was -100.87% in Q3 2025, compared to -115.24% in Q2 2025 and -105.54% in Q1 2025.